Author

Anna Fornwall

Observed names: A Fornwall, A. Fornwall

Institution: Quantify Research (Sweden)

Observed institution: Quantify Research (Sweden)

ORCID: 0009-0000-7364-6820

Observed ORCID: 0009-0000-7364-6820

OpenAlex ID: A5028667662

Prevalence, Characteristics, and Mortality of Patients with Transthyretin Amyloid Cardiomyopathy in the Nordic Countries

2022 · Rosa Lauppe, Johan Liseth Hansen, et al. · ESC Heart Failure · 51

Healthcare Resource Use of Patients with Transthyretin Amyloid Cardiomyopathy

2022 · Rosa Lauppe, Johan Liseth Hansen, et al. · ESC Heart Failure · 16

EP11.03-40 An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients

2023 · M. Skribek, A. Sierakowiak, et al. · Journal of Thoracic Oncology

POSB112 Health Care Resource Use of Transthyretin Amyloid Cardiomyopathy in Sweden

2022 · R Lauppe, J Liseth Hansen, et al. · Value in Health

EPV129/#529 Long-term clinical and economic value of pembrolizumab + lenvatinib compared with chemotherapy in previously treated advanced endometrial cancer patients in Sweden: a cost-effectiveness analysis

2021 · N. Upadhyay, L. Ralph, et al. · International Journal of Gynecological Cancer

Works count: 5

Citation count: 67

H-index: 2

I10-index: 2